ZabBio
CA - San DiegoBiotechnology
Focus: ZabBio is an early-stage oncology-focused monoclonal antibody biotech founded in 2023, based in San Diego. The company is publicly listed but remains in discovery/early development phase with minimal commercial presence.
Profile data last refreshed 10h ago · AI intelligence enriched 6d ago
Funding Stage
PUBLIC
Open Jobs
0
About ZabBio
AI assessmentNot HiringNo open roles listed right now. Follow ZabBio to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from ZabBio's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
KB15A Vaginal Film
Healthy SubjectsOpen Jobs (0)
No open positions listed yet.
Interview Prep Quick Facts
Help build intelligence for ZabBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.